25 of the Best Hematologists Near Me in paterson, NJ

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Colorectal Cancer, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration. Dr. Strauss is board certified in American Board Of Internal Medicine. Dr. Strauss is currently accepting new patients.

"Dr. Lentzsch is a Professor of Medicine and the Director of the Multiple Myeloma and Amyloidosis Program at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital. She received her medical and doctorate degrees from Humboldt University in Berlin, Germany, where she also completed her residency and fellowship. She did a research fellowship, studying the mechanism of action of thalidomide and its derivatives in multiple myeloma, in the Jerome Lipper Multiple Myeloma Center under the mentorship of Dr. Kenneth Anderson at the Dana-Farber Cancer Institute, Boston, MA, USA.Dr. Lentzsch was recruited in August 2004 to the University of Pittsburgh and University of Pittsburgh Cancer Institute (UPCI), PA, USA, and served as Clinical Director of the Multiple Myeloma Program at UPCI before accepting the position as Director of the Multiple Myeloma and Amyloidosis Program at Columbia University Medical Center. She cares primarily for patients with plasma cell dyscrasia including MGUS, Multiple Myeloma, Amyloidosis, POEMS and Waldenstrom's Macroglobulinemia.Dr. Lentzsch is an internationally recognized expert in the field of Multiple Myeloma and Amyloidosis. She serves as a SWOG Myeloma Committee Member, SWOG Study Coordinator and International Myeloma Foundation ""Black Swan Research Initiative"" committee member. She is a member of the standing advisory board for the evaluation of Secondary Primary Malignancies associated with IMiDs.". Dr. Lentzsch is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Tissue Biopsy. Dr. Lentzsch is currently accepting new patients.

Dr. Mapara is Professor of Medicine at Columbia University Medical Center and the Director of the Blood and Marrow Transplantation (BMT)/Cell Therapy Program at New York Presbyterian Hospital/Columbia University Medical Center. Dr. Mapara graduated from the University of Heidelberg Medical School/Germany, and received his post-graduate training in Internal Medicine and Hematology/Oncology at the Universities of Heidelberg and the University Medical Center Charite of the Humboldt University of Berlin in Germany. In addition, he completed a research fellowship at the Transplantation Biology Research Center of the Massachusetts General Hospital at the Harvard Medical School in Boston. As Assistant Professor of Medicine, he headed the Hematologic Intensive Care Unit and served as deputy director of the Stem Cell Transplantation unit at the University Medical Center Charite in Berlin, Germany. Before coming to Columbia, Dr. Mapara was Associate Professor of Medicine (with tenure) at the University of Pittsburgh Cancer Institute and served as the Director of the Adult Hematopoietic Stem Cell Transplantation Program. Dr. Mapara specializes in the care of patients with sickle cell disease and certain blood cancers (Multiple Myeloma, Amyloidosis) undergoing bone marrow transplantation and gene therapy.  His research is focused on developing novel approaches to make bone marrow transplantation and cell therapy safer for patients. Dr. Mapara is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Mapara is board certified in Hematology and Medical Oncology. Dr. Mapara is currently accepting new patients.

Andrew Pecora is a Hematologist and an Oncologist practicing medicine in Hackensack, New Jersey. Dr. Pecora is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Epithelioid Sarcoma, Melanoma, Adult Soft Tissue Sarcoma, Rhabdomyosarcoma Embryonal, and Tissue Biopsy. Dr. Pecora is board certified in Medical Oncology and American Board Of Internal Medicine . Dr. Pecora is currently accepting new patients.

Scott Rowley is a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Rowley is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Colonoscopy.

Gulam Manji, M.D., Ph.D. is an Associate Professor of Medicine at Columbia University Medical Center. Dr. Manji received his M.D. degree from Ross University School of Medicine in 2009 and completed his residency in internal medicine at Albany Medical College. He then completed his fellowship in Hematology/Oncology at NewYork-Presbyterian/Columbia, where his clinical focus was on the treatment of gastrointestinal malignancies, melanoma, and sarcoma under the mentorship of Dr. Gary Schwartz, Chief of Hematology and Oncology.Dr. Manji conducts translational research with the overall goal to developing new treatments for cancer. His focus is in gastrointestinal malignancies, particularly pancreas adenocarcinoma, on which he is conducting preclinical combination immunotherapy studies on genetically engineered mice with pancreas cancer in the Olive laboratory at the Herbert Irving Comprehensive Cancer Center. The combination immunotherapy preclinical proposal received the Young Investigator Award from the American Society of Clinical Oncology-2015. The goal of these preclinical studies is to bring promising new therapies to the clinic in an early phase clinical trials Dr. Manji's research career in identifying new genes and their implication in disease has led to numerous key publications and an issued patent.Dr. Manji cares for patients with gastrointestinal malignancies, with a particular focus on pancreatic and liver cancers, and sarcomas. He is the principal investigator of an investigator-initiated multicenter clinical trial that he wrote with Dr. Gary Schwartz in sarcoma and malignant peripheral nerve sheath tumors and is responsible for clinical trials conducted in liver, bile duct, gallbladder, and pancreas cancers at Columbia University Medical Center. Dr. Manji is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Malignant Peripheral Nerve Sheath Tumor, Familial Pancreatic Cancer, and Pancreatectomy. Dr. Manji is board certified in Internal Medicine and Medical Oncology. Dr. Manji is currently accepting new patients.

Dr. Eun-Ju Lee is part of the Weill Cornell Hematology and Medical Oncology Non-Malignant Hematology Program. She sees patients with non-malignant hematological diseases and her research efforts focus on the field of immune thrombocytopenia as well as in potential applications of whole exome sequencing in thrombophilia. After receiving her BA from Johns Hopkins University, Dr. Lee received her MD from Columbia University College of Physicians & Surgeons. After completing her residency at the New York-Presbyterian Hospital-Columbia Medical Center, she underwent a three-year fellowship in Hematology and Oncology at Yale-New Haven Hospital. Dr. Lee was a Doris Duke Clinical Research Fellow, and was awarded an NIH NIDDK student research training grant. Her publications include first authored articles in Blood Reviews and Clinical Lymphoma Myeloma and Leukemia. Dr. Lee is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP), Thrombocytopenia, Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Splenectomy. Dr. Lee is board certified in Hematology and Internal Medicine. Dr. Lee is currently accepting new patients.

Michael Maroules is a Hematologist practicing medicine in Clifton, New Jersey. Dr. Maroules is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Myelodysplastic Syndrome (MDS), Pulmonary Embolism, Splenectomy, and Bone Marrow Aspiration.

Andrew Bernstein is a Hematologist and an Oncologist practicing medicine in Pompton Plains, New Jersey. Dr. Bernstein is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Familial Pancreatic Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Bernstein is board certified in American Board Of Internal Medicine. Dr. Bernstein is currently accepting new patients.

Katherine Linder is a Hematologist and an Oncologist practicing medicine in Hackensack, New Jersey. Dr. Linder is highly rated in 22 conditions, according to our data. Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Aplastic Anemia, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Linder is board certified in Medical Oncology and American Board Of Internal Medicine . Dr. Linder is currently accepting new patients.

Stuart Goldberg is a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Goldberg is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Multiple Myeloma, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Tissue Biopsy.

Robert Tassan is a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Tassan is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Myelodysplastic Syndrome (MDS). Dr. Tassan is board certified in American Board Of Internal Medicine. Dr. Tassan is currently accepting new patients.

Mark Pascal is a Hematologist practicing medicine in Hackensack, New Jersey. Dr. Pascal is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Factor 11 Deficiency. Dr. Pascal is board certified in American Board Of Internal Medicine. Dr. Pascal is currently accepting new patients.

Jason Romancik is a Hematologist Oncology provider practicing medicine in Hackensack, New Jersey. Dr. Romancik is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma (MCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Romancik is board certified in Hematology and American Board Of Internal Medicine . Dr. Romancik is currently accepting new patients.

Martin Gutierrez is a Hematologist and an Oncologist practicing medicine in Hackensack, New Jersey. Dr. Gutierrez is highly rated in 5 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Gastroesophageal Junction Cancer, Gallbladder Adenocarcinoma, Squamous Cell Carcinoma of the Anal Canal (SCAC), and Tissue Biopsy. Dr. Gutierrez is board certified in American Board Of Internal Medicine. Dr. Gutierrez is currently accepting new patients.

Vijay Roy is a Hematologist and an Oncologist practicing medicine in Wayne, New Jersey. Dr. Roy is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, and Essential Thrombocythemia. Dr. Roy is board certified in American Board Of Internal Medicine. Dr. Roy is currently accepting new patients.

Rewais Morcus is a Hematologist and an Oncologist practicing medicine in Fair Lawn, New Jersey. Dr. Morcus is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Schizoaffective Disorder, Anemia, Acute Monoblastic Leukemia (AmoL), and Thrombocytopenia. Dr. Morcus is board certified in American Board Of Internal Medicine. Dr. Morcus is currently accepting new patients.

Yangsheng Zhou is a Hematologist Oncology provider practicing medicine in Hackensack, New Jersey. Dr. Zhou is highly rated in 1 condition, according to our data. His clinical expertise encompasses Waldenstrom Macroglobulinemia, Breast Cancer, Bone Tumor, and Prostate Cancer. Dr. Zhou is board certified in American Board Of Internal Medicine. Dr. Zhou is currently accepting new patients.

"Dr. Joseph Jurcic is a Professor of Medicine at Columbia University Medical Center and the Director of the Hematologic Malignancies Section within the Division of Hematology/Oncology. He specializes in Medical Oncology and focuses on leukemia, myelodysplastic syndromes, and myeloproliferative disorders. Based in New York, NY, Dr. Jurcic is affiliated with NewYork-Presbyterian/Columbia University Irving Medical Center. He received his M.D. from the Perelman School of Medicine at the University of Pennsylvania and completed his training at Barnes-Jewish Hospital and Memorial Sloan Kettering Cancer Center. He is board-certified in both Medical Oncology and Hematology.Dr. Jurcic's clinical expertise includes the treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndromes. His research interests encompass acute myeloid leukemia, radioimmunotherapy with alpha and beta particle-emitting radioisotopes, monoclonal antibody therapy, developing novel small molecule inhibitors, and molecular monitoring of minimal residual disease. Recognized as one of New York Magazine's ""Best Doctors"" from 2014 to 2024, he has authored or co-authored over 80 articles and book chapters. He has served as the principal investigator on more than 25 clinical trials. Additionally, Dr. Jurcic lectures at national and international conferences and is the Leukemia Section Editor for The Oncologist.". Dr. Jurcic is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Promyelocytic Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Jurcic is board certified in Hematology and Medical Oncology. Dr. Jurcic is currently accepting new patients.

Dr Novoselac earned his medical degree from University of Zagreb in 1996, and he completed his Internal Medicine residency and Hematology / Oncology fellowship at Lenox HIll Hospital in New York.Dr Novoselac is an Attending Physician at Lenox Hill Hospital and he participates in education and training of medical students, residents and fellow physicians.He is a member of the American Society of Clinical Oncology, American Society of Hematology, American College of Physicians and NY State Medical Society. Dr Novoselac provides care for a range of benign and malignant blood disorders as well as solid tumors, with a special clinical focus on lung cancer. Dr. Novoselac is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Blood Clots, Pleuropulmonary Blastoma, Factor 11 Deficiency, and Anemia. Dr. Novoselac is currently accepting new patients.

Email: gb96@cumc.columbia.edu. Dr. Bhagat is highly rated in 15 conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, Celiac Disease, and Endoscopy. Dr. Bhagat is board certified in Illinois Department Of Financial & Professional Regulation , Missouri State Board Of Registration, American Board Of Pathology/Anatomic & Clinical , Hematology, Anatomic Pathology And Clinical Pathology, and American Board Of Pathology/Hematology .

Steven Gruenstein is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Gruenstein is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Blood Clots, Anemia, Malabsorption, and Familial Colorectal Cancer. Dr. Gruenstein is currently accepting new patients.

Brenda Panzera is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Panzera is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Blood Clots, Breast Cancer, Paget Disease of the Breast, and Anemia. Dr. Panzera is board certified in American Board Of Internal Medicine/Medical Oncology and American Board Of Internal Medicine/Hematology. Dr. Panzera is currently accepting new patients.

Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract. As the Director of the HICCC Phase I Unit and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick’s clinical care and research are aligned to improve the effectiveness of, and limit side effects from, emerging cancer treatments. These efforts entail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events from immunotherapy. Dr. Henick is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Henick is board certified in Internal Medicine. Dr. Henick is currently accepting new patients.

Jason Suh is a Hematologist and an Oncologist practicing medicine in Paramus, New Jersey. Dr. Suh is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Burkitt Lymphoma, Multiple Myeloma, Familial Pancreatic Cancer, and Bone Marrow Aspiration. Dr. Suh is currently accepting new patients.